They constructed VEGFR-2-targeted liposomes modified with PEG and DSPE-PEG-APRPG to deliver Dox, with the ability of long-circulating characteristics, enhanced accumulation in tumor and efficient tumor growth suppression in vivo (Maeda et al., 2004). Here, KDR is linked to neoplasm.